After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of NewAmsterdam Pharma Company NV is $3.78B. A total of 0.55 million shares were traded on the day, compared to an average of 938.23K shares.
In the most recent transaction, Somaiya Mayur Ian sold 60,216 shares of NAMS for 31.96 per share on Jan 20 ’26. After the transaction, the Chief Financial Officer now owns 58,382 company shares. In a previous transaction on Jan 21 ’26, Somaiya Mayur Ian sold 39,784 shares at 33.59 per share. NAMS shares that Chief Financial Officer owns now total 58,382.
Among the insiders who bought shares, Mayur Somaiya acquired of 200,000 shares on Jan 20 ’26 at a per-share price of $31.65. In another insider transaction, Kastelein Johannes Jacob Piete sold 6,000 shares at $33.25 per share on Jan 05 ’26. Company shares held by the Chief Scientific Officer now total 73,481.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, NAMS has a high of $42.00 and a low of $14.06.
As of this writing, NAMS has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.09 per share and a lower estimate of -$0.53. The company reported an EPS of -$0.9 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NAMS’s latest balance sheet shows that the firm has $60.11M in Cash & Short Term Investments as of fiscal 2021. There were $185.68k in debt and $11.19M in liabilities at the time. Its Book Value Per Share was $6.43, while its Total Shareholder’s Equity was $56.37M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock.
